CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS
$625,318FY2018Defense Health AgencyDOD
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii